Centiva Capital’s Chemours CC Stock Holding History

Centiva Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,000	Closed	-$177K	–	1723
2025 Q4	$177K	Buy	+15,000	New	+$193K	﹤0.01%	1006
2024 Q3	–	Sell	-25,000	Closed	-$564K	–	2180
2024 Q2	$564K	Buy	+25,000	New	+$655K	0.01%	1082

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

WHCM

Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Centiva Capital's CC Position: Q3 2025 in Review

Centiva Capital sold out of Chemours (CC) in Q3 2025, closing a stake of 53,912 shares — an estimated $617K sold.

Centiva Capital first reported a position in CC in Q3 2019 and held it in 7 quarters. The position peaked at $617K in Q2 2025. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

Centiva Capital reported no remaining Chemours position as of Q3 2025 after selling out during the quarter.
Centiva Capital sold 53,912 Chemours shares in Q3 2025, an estimated $617K.
Centiva Capital first reported a position in Chemours in Q3 2019 and held it in 7 quarters.
Centiva Capital's Chemours position peaked at $617K in Q2 2025.
428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.